WallStreetZenWallStreetZen

NASDAQ: SBFM
Sunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?

Open Broker Account

Insider buying vs selling

Have Sunshine Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Camille SebaalyCFOSecretary2022-06-0325,000$1.22
$30.50kBuy
Steve N. SlilatyChief Executive Officer2022-02-18990,000$0.10
$99.00kSell

1 of 1

SBFM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SBFM insiders and whales buy or sell their stock.

SBFM Shareholders

What type of owners hold Sunshine Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bridgeway Capital Management LLC3.01%568,400$457.56kInstitution
Camille Sebaaly0.76%144,465$116.29kInsider
Virtu Financial LLC0.25%47,861$38.53kInstitution
Bank Of Montreal0.16%31,000$24.96kInstitution
Two Sigma Securities LLC0.11%20,722$16.68kInstitution
Geode Capital Management LLC0.11%20,179$16.24kInstitution
Dakota Wealth Management0.11%20,000$16.10kInstitution
Steve N. Slilaty0.05%10,000$8.05kInsider
Tower Research Capital LLC Trc0.04%8,128$6.54kInstitution
Advisor Group Holdings Inc0.04%7,528$6.06kInstitution

1 of 3

SBFM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SBFM3.90%0.82%Net Selling
JUPW14.43%35.82%Net Buying
AKAN1.67%0.00%
CYTH0.52%99.48%Net BuyingNet Buying
PLXP27.55%25.72%Net Buying

Sunshine Biopharma Stock Ownership FAQ

Who owns Sunshine Biopharma?

Sunshine Biopharma (NASDAQ: SBFM) is owned by 3.90% institutional shareholders, 0.82% Sunshine Biopharma insiders, and 95.28% retail investors. Camille Sebaaly is the largest individual Sunshine Biopharma shareholder, owning 144,465.00 shares representing 0.76% of the company. Camille Sebaaly's Sunshine Biopharma shares are currently valued at $119.76k.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.